Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody

Pharmacotherapy

Volumn 32, Issue 11, 2012, Pages

  Ruggero, Michael A ^a   Abdelghany, Osama ^a   Topal, Jeffrey E ^b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse drug reactions; Drug safety; Immunology; Infectious disease; Thrombocytopenia.; Vancomycin

Indexed keywords

CEFTAZIDIME; D DIMER; DAPTOMYCIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG WITHDRAWAL; FEVER; FIBRINOGEN BLOOD LEVEL; HUMAN; LEUKOCYTOSIS; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; SPUTUM CULTURE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; DIAGNOSIS, DIFFERENTIAL; DOXYCYCLINE; DRUG MONITORING; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, STAPHYLOCOCCAL; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECURRENCE; STAPHYLOCOCCAL INFECTIONS; THROMBOCYTOPENIA; VANCOMYCIN;

EID: 84871560026     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1132     Document Type: Article

References (13)

1. Klevens RM, Edwards JR, Tenover FC, et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006;42:389-91 (Pubitemid 43122317)
2. Jarvis WR, Jarvis AA, Chinn RY. National prevalence of methicillin- resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am J Infect Control 2012;40:194-200
3. Pakyz AL, MacDougall C, Oinonen M, et al. Trends in antibacterial use is US academic health centers. Arch Inter Med 2008;168:2254-60
4. Bosso JA, Nappi J, Rudisill C, et al. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother 2011;55:5475-9
5. Lodise TP, Patel N, Lomaestro BM, et al. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009;49:507-14
6. Prabaker K, Tran T, Pratummas T, et al. Association of vancomycin trough levels with nephrotoxicity. In: Program and abstract of the 47th annual meeting of Infectious Diseases Society of America, Arlington, VA, IDSA, 2009. Abstract 192
7. Christie DJ, van Buren N, Lennon SS, Putnam JL. Vancomycin- dependent antibodies associated with thrombocytopenia and refractoriness to platelet transfusion in patients with leukemia Blood 1990;75:518-23 (Pubitemid 20035286)
8. BloodCenter of Wisconsin. Home page. Available from http:// www.bcw.edu/ucmro/groups/public/documents/documents/000155.pdf. Accessed March 28, 2011
9. Bougie DW, Wilker PR, Aster RH. Patients with quinineinduced immune thrombocytopenia have both "drug-dependent" and "drug- specific" antibodies. Blood 2006;108:922-7 (Pubitemid 44154626)
10. Shah RA, Musthaq A, Khardori N. Vancomycin-induced thrombocytopenia in a 60-year-old man: a case report. J Med Case Reports 2009;3:7290.1-4
11. Mizon P, Kiefel V, Mannessier L, Mueller-Eckhardt C, et al Thrombocytopenia induced by vancomycin dependent platelet antibody. Vox Sang 1997;73:49-51 (Pubitemid 27363961)
12. Drygalski AV, Curtis BR, Bougie DW, et al. Vancomycininduced immune thrombocytopenia. N Engl J Med 2007;356:904-10
13. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45 (Pubitemid 12149145)